Vaginal Ecosystem and Network in the United States Study

About

Brief Summary

The central premise of this study is that the intricate balance and diversity of the vaginal microbiome plays a pivotal role in the onset, progression, and severity of various gynecological conditions. Specifically, the research aims to investigate how imbalances in microbial communities, such as the overgrowth of pathogenic bacteria or the depletion of beneficial ones, are linked to conditions like Bacterial Vaginosis, Candidiasis, Urinary Tract Infections, Vaginal Atrophy, and others. By employing PCR testing and the outcomes of next-generation sequencing (NGS) of the microbiome, the study seeks to identify distinct microbial profiles and patterns that are characteristic of each condition. This nuanced understanding is expected to lead to more accurate and early diagnosis, facilitating personalized and effective treatment strategies that go beyond the conventional, often indiscriminate use of antibiotics.

Study Type
The nature of the investigation or investigational use for which clinical study information is being submitted. Learn more
Observational
Phase
N/A

Eligibility

Gender
Female
Healthy Volunteers
Yes
Minimum Age
18 Years
Maximum Age
89 Years

Inclusion Criteria:

  • Healthy cis-gender women between ages 18 and 89

Exclusion Criteria:

  • Pregnant or trying to conceive (i.e. IVF, IUI)
Study Stats
Protocol No.
24-5804
Category
Other Cancer
Principal Investigator
Puja S. Venkat, MD
Puja S. Venkat, MD
Radiation Oncology
Puja S. Venkat, MD
Contact
  • Sophia Parmisano
Location
  • UCLA Westwood
For Providers
NCT No.
NCT06472765
For detailed technical eligibility, visit ClinicalTrials.gov.